Trimethylsilyl trifluoromethanesulfonate

We are Trimethylsilyl trifluoromethanesulfonate CAS:27607-77-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Product Name: Trimethylsilyl trifluoromethanesulfonate
Other Name: Trimethylsilyl Triflate
CAS No: 27607-77-8
MF: C4H9F3O3SSi
MW: 222.25800
Density: 1.228 g/mL at 25 °C(lit.)
Boiling point: 77 °C80 mm Hg(lit.)
Flash point: 78 °F
Refractive index: n20/D 1.36(lit.)
UN Number: UN2920
UN Proper Shipping Name: CORROSIVE LIQUID, FLAMMABLE, N.O.S.
Transport hazard class: 3
Packing group: II
 
Specification
Appearance: Yellow transparent liquid
Assay: ≥99%
Cl: ≤100pm
 
Application
It is an important trifluoromethanesulfonic acid derivative and is an important pharmaceutical intermediate, pesticide intermediate and organic synthetic structural unit.
It is a very effective methylsilylation reagent.
It can participate in the reaction of carbon-carbon bond formation and carbon chain growth of organic compounds.
In some chemical reactions, it is also used as a Lewis acid catalyst.
 
Package: 40L stainless steel barrel
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

Trimethylsilyl trifluoromethanesulfonate


Related News: Catalent, a global leader in clinical supply services, recently announced the launch of its new CTSuccessTM clinical trial planning service, designed to support trial sponsors with earlier, more proactive and robust clinical supply chain planning, and reduce the risk of delays and budget overspend common to clinical trials as they progress.ethyl 5-(ethoxycarbonylsulfamoyl)-1-methylpyrazole-4-carboxylate As proof-of-principle for the unique advantages arising from selecting a single engineered iPSC clone for the production of CAR T-cell therapy, the scientists assessed 747 clones after engineering a pool of cells using CRISPR. It was found that only about 2% of clones met the Company’s standards for overall quality including containing both bi-allelic disruption of the TCR, proper insertion of the CAR into the TRAC locus without random transgene integrations, and no evidence of off-target genomic modifications or translocations.Clorhidrato de piridoxal CAS:65-22-5 As proof-of-principle for the unique advantages arising from selecting a single engineered iPSC clone for the production of CAR T-cell therapy, the scientists assessed 747 clones after engineering a pool of cells using CRISPR. It was found that only about 2% of clones met the Company’s standards for overall quality including containing both bi-allelic disruption of the TCR, proper insertion of the CAR into the TRAC locus without random transgene integrations, and no evidence of off-target genomic modifications or translocations.6-cloro-1-hexanol CAS:2009-83-8 On the basis of achieving low-cost and high-quality processes, production capacity will become the core driving force for API companies to break through sales bottlenecks.On the basis of achieving low-cost and high-quality processes, production capacity will become the core driving force for API companies to break through sales bottlenecks.

Related Products
Product Name
5-Fluoro-2-nitrophenol View Details
2-hydroxyacetophenone Cas:582-24-1 View Details
Edaravone View Details
N-Z-L-serine methyl ester manufacturer 2-Bromo-5-chlorotoluene manufacturer 4-Bromo-1-fluoro-2-nitrobenzene manufacturer 5-Methyl-3-nitropyridin-2-amine manufacturer 4-Propyl-3′-Fluorobiphenyl-4′-Boronic Acid manufacturer